After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that Elevance Health Announces Closing of Paragon Healthcare Acquisition.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Elevance Health Inc is listed on the NYSE in the Healthcare sector while operating in the Healthcare Plans industry. The current market capitalization of Elevance Health Inc is $120.98B. A total of 0.69 million shares were traded on the day, compared to an average of 1.01M shares.
In the most recent transaction, Kendrick Charles Morgan JR sold 2,432 shares of ELV for 500.46 per share on Mar 08 ’24. After the transaction, the EVP & President, Commercial now owns 15,840 company shares. In a previous transaction on Mar 06 ’24, Penczek Ronald W sold 916 shares at 504.58 per share. ELV shares that CAO & Controller owns now total 1,764.
Among the insiders who sold shares, Haytaian Peter D disposed of 21,095 shares on Mar 04 ’24 at a per-share price of $500.18. This resulted in the EVP & Pres Carelon & CarelonRx holding 18,887 shares of ELV after the transaction. In another insider transaction, PERU RAMIRO G sold 753 shares at $500.00 per share on Feb 07 ’24. Company shares held by the Director now total 9,109.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Elevance Health Inc pays an annual dividend of $6.07, resulting in a dividend yield of 1.17%, and it has a price to earnings (P/E) ratio of 20.66. ELV’s most recent ex-dividend date was 3/7/2024 when it declared a $1.63 quarterly dividend that was paid in cash on 3/22/2024. Previously, the company paid the dividend on 12/21/2023 with an ex-dividend date of 12/5/2023. The ELV stock dividend was $1.48 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ELV has a high of $519.37 and a low of $412.00.
As of this writing, ELV has an earnings estimate of $10.45 per share for the current quarter. EPS was calculated based on a consensus of 16 estimates, with a high estimate of $10.83 per share and a lower estimate of $10.04. The company reported an EPS of $8.99 in the last quarter, which was 6.50% higher than expectations of $8.44.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ELV’s latest balance sheet shows that the firm has $31.15B in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $168.64, while its Total Shareholder’s Equity was $36.13B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ELV is Buy with a score of 4.81.
